Ignite Creation Date:
2024-05-06 @ 7:15 AM
Last Modification Date:
2024-10-26 @ 11:46 AM
Study NCT ID:
NCT02501551
Status:
UNKNOWN
Last Update Posted:
2021-04-05
First Post:
2015-03-05
Brief Title:
Regorafenib C-kit Mutated Malignant Melanoma 2nd Line Therapy
Sponsor:
Yonsei University
Organization:
Yonsei University
Organization Data
Organization:
Yonsei University
Class:
OTHER
Study ID:
4-2014-0573
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Yonsei University
Lead Sponsor Class:
OTHER
Responsible Party:
Sang Joon Shin
Responsible Party Title:
Associate Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Yonsei University
Old Name:
None
Old Organization:
None